Search results for: 'Image-Guided Therapy Market'

This research identifies some the key developments across CAR-T cell therapies and provides insights across technological, IP, and investment landscapes. The study also provides an analysis of the competitive landscape while highlighting the key growth opportunities within the CAR-T cell therapy platform.

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, medical imaging, and diagnostics industry. The issue includes advanced medical devices such as minimally invasive cryoablation therapy, material coating technology for medical devices, wireless and cathet...

The global CGT therapeutics market is transitioning from a niche, high-complexity segment into a mainstream, high-growth therapeutic class. Driven by scientific breakthroughs, accelerated regulatory pathways, and the entry of next-generation platforms—including in vivo CRISPR gene editing, allogeneic “off-the-shelf” cell therapies, and automated sm...

The small animal imaging or in vivo preclinical imaging market began to come into existence from the early 1990s when scientists studying biology and disease processes realized that clinical image could help them reduce the cost of research and time span of their animal studies. At present, medical imaging is an important tool in research applicati...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

16 May 2022  |  North America  |  Market Research

Global Interventional X-ray (IXR) Growth Opportunities

Combining Interventional X-ray and Surgical C-arm with Image-guided Therapies will Accelerate Transformational Growth

Infographics

×

This Frost & Sullivan study analyzes the global interventional X-ray (IXR) market. The research scope includes market trends (utilization of conventional and emerging clinical applications, growth indicators, factors influencing RoI, critical unmet needs and potential game-changing strategies, growth opportunities for fixed IXR and surgical C-arm s...

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, and it is built on primary interviews with the peo...

Comprehensive wound assessment is vital to understand the nature of wounds and devise evidence-based and cost-effective therapeutic interventions. However, traditionally used methods for wound diagnosis and monitoring cannot accurately measure wound dimensions, require physical contact with the wound, which causes discomfort to the patients, and ca...